The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-tert-butyl-3-(3-(5-(4-(piperidin-1-yl)piperidin-1-yl)-1H-benzo[d]imidazol-2-yl)-1H-indazol-4-yl)urea ID: ALA379740
PubChem CID: 136038593
Max Phase: Preclinical
Molecular Formula: C29H38N8O
Molecular Weight: 514.68
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)NC(=O)Nc1cccc2[nH]nc(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)c12
Standard InChI: InChI=1S/C29H38N8O/c1-29(2,3)33-28(38)32-22-8-7-9-23-25(22)26(35-34-23)27-30-21-11-10-20(18-24(21)31-27)37-16-12-19(13-17-37)36-14-5-4-6-15-36/h7-11,18-19H,4-6,12-17H2,1-3H3,(H,30,31)(H,34,35)(H2,32,33,38)
Standard InChI Key: RQIXEOXMOHDTLC-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
14.8849 -20.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8779 -21.2376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5876 -21.6552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5971 -20.0026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3121 -20.4163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3069 -21.2429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0915 -21.5032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5816 -20.8375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0999 -20.1658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3596 -19.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1455 -19.1378 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8792 -18.7177 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3679 -18.0535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1504 -18.3172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7680 -17.7720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6044 -16.9629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8176 -16.7019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2033 -17.2489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6509 -15.8943 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2741 -15.3462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1101 -14.5418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3284 -14.2782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7102 -14.8256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8739 -15.6365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1646 -13.4700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7851 -12.9296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6241 -12.1246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8434 -11.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2233 -12.4031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3838 -13.2146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5990 -19.1780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8857 -18.7642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8876 -17.9396 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1706 -19.1748 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4575 -18.7610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7403 -18.3477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8702 -18.0471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0473 -19.4763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17 18 1 0
18 13 2 0
8 9 2 0
17 19 1 0
19 20 1 0
9 5 1 0
4 1 2 0
9 10 1 0
10 11 1 0
5 6 2 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
22 25 1 0
25 26 1 0
11 14 1 0
13 12 1 0
12 10 2 0
2 3 2 0
3 6 1 0
25 30 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
13 14 1 0
4 31 1 0
1 2 1 0
31 32 1 0
14 15 2 0
32 33 2 0
5 4 1 0
32 34 1 0
15 16 1 0
34 35 1 0
6 7 1 0
35 36 1 0
16 17 2 0
35 37 1 0
7 8 1 0
35 38 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 514.68Molecular Weight (Monoisotopic): 514.3169AlogP: 5.48#Rotatable Bonds: 4Polar Surface Area: 104.97Molecular Species: BASEHBA: 5HBD: 4#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.88CX Basic pKa: 9.78CX LogP: 3.89CX LogD: 1.77Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.29Np Likeness Score: -1.47
References 1. McBride CM, Renhowe PA, Heise C, Jansen JM, Lapointe G, Ma S, Piñeda R, Vora J, Wiesmann M, Shafer CM.. (2006) Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases., 16 (13): [PMID:16603352 ] [10.1016/j.bmcl.2006.03.069 ]